BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6222948)

  • 1. Inhibition of the induction of contrasuppression by antisera against tumor-associated surface antigens on methylcholanthrene-induced sarcomas.
    Flood PM; DeLeo AB; Old LJ; Gershon RK
    Haematol Blood Transfus; 1983; 28():486-8. PubMed ID: 6222948
    [No Abstract]   [Full Text] [Related]  

  • 2. Similarities between transplantation antigens on methylcholanthrene-induced sarcomas and T-cell regulatory molecules.
    Flood PM; Deleo AB; Old LJ; Gershon RK
    Ann N Y Acad Sci; 1983; 418():206-19. PubMed ID: 6231877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules.
    Flood PM; DeLeo AB; Old LJ; Gershon RK
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1683-7. PubMed ID: 6220407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors.
    Tanimoto M; Takahashi T; Nishizuka Y
    Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
    Ahrlund-Richter L; Klein E; Merino F
    Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.
    Tanaka T; Yamagishi H; Pellis NR; Kahan BD
    Cancer Immunol Immunother; 1982; 13(1):48-52. PubMed ID: 6760958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    Bloom ET
    J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas.
    Hellström I; Hellström KE; Sjögren HO
    Cell Immunol; 1970 May; 1(1):18-30. PubMed ID: 5523573
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity.
    Bataillon G; Pross H; Klein G
    Int J Cancer; 1975 Aug; 16(2):255-65. PubMed ID: 1150353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of theta-plus-lymphocytes in the regional and distant lymph nodes C3H/Sn strain mice during development of primary methylcholanthrene sarcomas].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Biull Eksp Biol Med; 1975 Jan; 79(1):57-9. PubMed ID: 1078631
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.
    Twitty CG; Jensen SM; Hu HM; Fox BA
    Clin Cancer Res; 2011 Oct; 17(20):6467-81. PubMed ID: 21810919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
    Fritze D; Kern DH; Waldman SR; Pilch YH
    Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma.
    DeLeo AB; Chang KS; Wivel NA; Appella E; Old LJ; Law LW
    Int J Cancer; 1982 Jun; 29(6):687-93. PubMed ID: 7107069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
    Kosugi A; Takai Y; Ogata M; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1985 May; 37(5):629-39. PubMed ID: 3156939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.